Alkem Laboratories per share figures

Share price at each year-end
Tap a line for its trendCurrentlast 12MFY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
₹180.44₹192.51₹181.11₹150.19₹82.31
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
₹180.44₹192.51₹181.11₹150.19₹82.31
₹1,156.01₹1,156.01₹1,002.50₹862.57₹756.61
₹1,261.50₹1,230.64₹1,084.44₹1,059.61₹970.24
—₹164.20₹160.00₹162.95₹140.74
₹112.57₹112.57₹103.49₹141.26₹121.25
—₹51.33₹42.21₹45.21₹44.29
12.012.012.012.012.0
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

ALKEM₹5,079.00

Alkem Laboratories Ltd.

· Pharma & Health
₹ CrorePeersMANKINDTORNTPHARMIPCALABLUPINFORTISAUROPHARMALAURUSLABSBIOCONMcap ₹60,719 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
₹ per share
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Current/LTM
TTM · last close
Basic EPS82.31150.19181.11192.51180.44
Diluted EPS82.31150.19181.11192.51180.44
Book Value per Share756.61862.571,002.501,156.011,156.01
Revenue per Share970.241,059.611,084.441,230.641,261.50
Cash Flow per Share140.74162.95160.00164.20—
Free Cash Flow per Share121.25141.26103.49112.57112.57
Dividends per Share44.2945.2142.2151.33—
Shares Outstanding (cr)12.012.012.012.012.0
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.